Clinical Trial Update: Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy

View source ↗

Summary

This completed clinical trial evaluated blood and urine kidney injury biomarkers to facilitate early detection of renal adverse drug events in pediatric cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Kidney Injury

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Kidney Impairment | Status: COMPLETED